64 related articles for article (PubMed ID: 32783399)
1. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Based Nomogram for Predicting the Aggressiveness of Papillary Thyroid Carcinoma in Adolescents and Young Adults.
Sun P; Wei Y; Chang C; Du J; Tong Y
Acad Radiol; 2024 Feb; 31(2):523-535. PubMed ID: 37394408
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling to predict overall survival risk in gastric cancer: development and validation of a nomogram to optimize clinical management.
Ma X; Chen H; Wang G; Li L; Tao K
J Cancer; 2020; 11(15):4352-4365. PubMed ID: 32489454
[TBL] [Abstract][Full Text] [Related]
5. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Bao X; Anastasov N; Wang Y; Rosemann M
J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract][Full Text] [Related]
7. A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer.
Li M; Zhu C; Xue Y; Miao C; He R; Li W; Zhang B; Yu W; Huang X; Lv M; Xu Y; Huang Q
Br J Cancer; 2023 May; 128(9):1681-1689. PubMed ID: 36828869
[TBL] [Abstract][Full Text] [Related]
8. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
[TBL] [Abstract][Full Text] [Related]
9. Construction of methylation-associated nomogram for predicting the recurrence-free survival risk of stage I-III lung adenocarcinoma.
Liu Y; Wang B; Shi S; Li Z; Wang Y; Yang J
Future Oncol; 2021 Sep; ():. PubMed ID: 34476982
[TBL] [Abstract][Full Text] [Related]
10. Preoperative risk stratification for patients with ≤ 1 cm papillary thyroid carcinomas based on preoperative blood inflammatory markers: construction of a dynamic predictive model.
Zhao L; Hu T; Cai Y; Zhou T; Zhang W; Wu F; Zhang Y; Luo D
Front Endocrinol (Lausanne); 2023; 14():1254124. PubMed ID: 38189045
[TBL] [Abstract][Full Text] [Related]
11. Nomogram model for predicting the risk of post-stroke depression based on clinical characteristics and DNA methylation.
Luo S; Liu F; Liao Q; Chen H; Zhang T; Mao R
PeerJ; 2023; 11():e16240. PubMed ID: 37846310
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for lung metastasis in pediatric differentiated thyroid cancer: a clinical prediction study.
Kuang HF; Lu WL
J Pediatr Endocrinol Metab; 2024 Mar; 37(3):250-259. PubMed ID: 38332686
[TBL] [Abstract][Full Text] [Related]
13. Association of Promoter Methylation Patterns with Expression of MAPK14 in Tissue of Papillary Thyroid Cancer Patients.
Shahdust M; Zarredar H; Asadi M; Caner A; Dehghan M; Soleimani Z; Seyednejad F; Raeisi M
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3509-3515. PubMed ID: 37898857
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancer.
Sun M; Zhao B; Chen T; Yao L; Li X; Hu S; Chen C; Gao X; Tang C
Thyroid Res; 2024 Apr; 17(1):7. PubMed ID: 38556856
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of single-nucleotide polymorphism signature for nephrolithiasis recurrence: a 5-year prospective study.
Zhu W; Zhang X; Zhou Z; Sun Y; Zhang G; Duan X; Huang Z; Ai G; Liu Y; Zhao Z; Zhong W; Zeng G
Clin Kidney J; 2023 Nov; 16(11):2205-2215. PubMed ID: 37915892
[TBL] [Abstract][Full Text] [Related]
16. Role of pathologists in nomogram development: reply.
Aksoy YA; Chou A; Mahjoub M; Sheen A; Sioson L; Ahadi MS; Gill AJ; Fuchs TL
Pathology; 2023 Dec; 55(7):1049. PubMed ID: 37821340
[No Abstract] [Full Text] [Related]
17. MiR-3121-3p promotes tumor invasion and metastasis by suppressing Rap1GAP in papillary thyroid cancer
Xu M; Zhou J; Zhang Q; Le K; Xi Z; Yi P; Zhao X; Tan J; Huang T
Ann Transl Med; 2020 Oct; 8(19):1229. PubMed ID: 33178761
[TBL] [Abstract][Full Text] [Related]
18. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Chen H; Deng Q; Wang W; Tao H; Gao Y
J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
[TBL] [Abstract][Full Text] [Related]
19. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
Gao F; Xu Q; Jiang Y; Lu B
Sci Rep; 2023 Mar; 13(1):3759. PubMed ID: 36882567
[TBL] [Abstract][Full Text] [Related]
20. Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer.
Zhu J; Zhang L
Medicine (Baltimore); 2022 Dec; 101(49):e32205. PubMed ID: 36626527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
